Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Comella

Showing results (381-390 of 685) with videos related to

Pageof 69
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2010
Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placeboMatthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 23, 2018
Biodegradable-Polymer Versus Polymer-Free Drug-Eluting Stents for the Treatment of Coronary Artery DiseaseJason Nogic, Paul Thein, Sam Mirzaee, et al.
Critical Reviews in Oncology/Hematology|January 22, 2005
A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108Pasquale Comella, Antonio Gambardella, Antonio Farris, et al.
British Journal of Pharmacology|January 19, 2005
Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS-dependent pathwayFrancisco J Fernandez-Gomez, Maria F Galindo, Maria Gómez-Lázaro, et al.
Journal of Cancer Research and Clinical Oncology|August 23, 2008
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401Pasquale Comella, Bruno Massidda, Gianfranco Filippelli, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|April 24, 2013
Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical DystoniaHubert H Fernandez, Eric J Pappert, Cynthia L Comella, et al.
The Journal of Biological Chemistry|February 23, 2013
Chromatin collapse during caspase-dependent apoptotic cell death requires DNA fragmentation factor, 40-kDa subunit-/caspase-activated deoxyribonuclease-mediated 3'-OH single-strand DNA breaksVictoria Iglesias-Guimarais, Estel Gil-Guiñon, María Sánchez-Osuna, et al.
Journal of Neurology|April 23, 2014
Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)P David Charles, Charles H Adler, Mark Stacy, et al.
Developmental Medicine and Child Neurology|January 26, 2023
Determinants of gait dystonia severity in cerebral palsyBhooma R Aravamuthan, Toni S Pearson, Keisuke Ueda, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)R Labianca, G Pancera, S Barni, et al.
Pageof 69

Showing results (381-390 of 685) with videos related to

Sort By:
Pageof 69
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 2010
Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placeboMatthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 23, 2018
Biodegradable-Polymer Versus Polymer-Free Drug-Eluting Stents for the Treatment of Coronary Artery DiseaseJason Nogic, Paul Thein, Sam Mirzaee, et al.
Critical Reviews in Oncology/Hematology|January 22, 2005
A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108Pasquale Comella, Antonio Gambardella, Antonio Farris, et al.
British Journal of Pharmacology|January 19, 2005
Malonate induces cell death via mitochondrial potential collapse and delayed swelling through an ROS-dependent pathwayFrancisco J Fernandez-Gomez, Maria F Galindo, Maria Gómez-Lázaro, et al.
Journal of Cancer Research and Clinical Oncology|August 23, 2008
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401Pasquale Comella, Bruno Massidda, Gianfranco Filippelli, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|April 24, 2013
Efficacy and Safety of IncobotulinumtoxinA in Subjects Previously Treated with Botulinum Toxin Versus Toxin-Naïve Subjects with Cervical DystoniaHubert H Fernandez, Eric J Pappert, Cynthia L Comella, et al.
The Journal of Biological Chemistry|February 23, 2013
Chromatin collapse during caspase-dependent apoptotic cell death requires DNA fragmentation factor, 40-kDa subunit-/caspase-activated deoxyribonuclease-mediated 3'-OH single-strand DNA breaksVictoria Iglesias-Guimarais, Estel Gil-Guiñon, María Sánchez-Osuna, et al.
Journal of Neurology|April 23, 2014
Cervical dystonia and pain: characteristics and treatment patterns from CD PROBE (Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy)P David Charles, Charles H Adler, Mark Stacy, et al.
Developmental Medicine and Child Neurology|January 26, 2023
Determinants of gait dystonia severity in cerebral palsyBhooma R Aravamuthan, Toni S Pearson, Keisuke Ueda, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)R Labianca, G Pancera, S Barni, et al.
Pageof 69